The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL

NCT00347737 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: teriparatide

Sponsor

Leland Graves III, MD

Collaborators

[object Object]